301. [Treatment of cancer and hematological malignancy in elderly people (Part II)].
- Author
-
Ladoire S, Ghiringhelli F, Manckoundia P, Casasnovas RO, Solary E, Besancenot JF, and Pfitzenmeyer P
- Subjects
- Acute Disease, Age Factors, Aged, Aged, 80 and over, Female, Humans, Male, Hematologic Neoplasms therapy, Leukemia, Myeloid therapy, Lymphoma, Non-Hodgkin therapy, Multiple Myeloma therapy, Ovarian Neoplasms therapy, Prostatic Neoplasms therapy, Urinary Bladder Neoplasms therapy
- Abstract
Purpose: Fifty percents of cancer arise in people older than 65-year-old. Most clinical trials in cancer treatment are limited in patients younger than 65-year-old. We review literature-describing particularity of cancer treatment in elderly patients., Current Knowledge and Key Points: Therapeutic decisions should be based on an estimation of the patient's life expectancy, and risks and benefits should be weighted up accordingly. Geriatric oncology is made of a geriatric evaluation of patient and of knowledge of clinical trial about elderly patients., Future Prospects and Projects: We present in this issue the principle of geriatric evaluation and the results of recent clinical trial on elderly cancer patients.
- Published
- 2005
- Full Text
- View/download PDF